Zylox-Tonbridge Medical Statements
21
Zylox-Tonbridge Medical Income Statement
B
M
CNY (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
230.13
100
59.485
25.8
170.65
74.2
124.24
54
121.95
53
252.77
109.8
-82.125
-35.7
46.909
20.4
—
0
-35.223
-15.3
0.291
0.1
-35.514
-15.4
-0.108
329.68
181.35
100
44.155
24.3
137.19
75.7
136.86
75.5
143.58
79.2
283.08
156.1
-145.89
-80.4
67.164
37
—
0
-88.051
-48.6
—
0
-88.051
-48.6
-0.267
329.78
152.74
100
37.266
24.4
115.48
75.6
90.616
59.3
99.801
65.3
193.07
126.4
-77.597
-50.8
52.112
34.1
—
0
-25.504
-16.7
—
0
-25.504
-16.7
-0.077
330.99
106.43
100
26.671
25.1
79.757
74.9
116.04
109
114.2
107.3
221.59
208.2
-141.83
-133.3
11.858
11.1
—
0
-129.97
-122.1
—
0
-129.97
-122.1
-0.506
256.79
71.484
100
19.36
27.1
52.124
72.9
46.35
64.8
79.08
110.6
128.43
179.7
-76.31
-106.8
6.602
9.2
—
0
-69.717
-97.5
—
0
-69.717
-97.5
-0.21
332.4